Physician profile
Devvin Cubra
NPI 1194300285
$3,327.98
in general payments reported to CMS, 2019-2025
11 companies · $509 in 2025
The $509 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,800 · 2024: $19.24 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $528.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cdc Medical LLC | $2,400.00 | 2022 | |
| Dexcom, INC. | $238.88 | 2022 | |
| Davol INC. | $166.49 | 2025 | Arista |
| Edwards Lifesciences Corporation | $160.77 | 2022 | |
| Stryker Corporation | $114.06 | 2025 | Mako |
| Smith+Nephew, INC. | $89.95 | 2025 | Redapt, Evos Mini, Evos |
| Bioventus LLC | $51.47 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $47.65 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Vertex Pharmaceuticals Incorporated | $22.76 | 2025 | |
| Anika Therapeutics, INC. | $21.25 | 2025 | Integrity Implant |
| Vericel Corporation | $14.70 | 2025 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devvin Cubra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.